Aadi Bioscience Inc

NAS:AADI (USA)  
$ 3.00 +0.14 (+4.9%) 11:09 PM EST
At Loss
P/B:
1.02
Market Cap:
$ 70.59M
Enterprise V:
$ 23.11M
Volume:
250.09K
Avg Vol (2M):
380.07K
Trade In:
Volume:
250.09K
At Loss
Avg Vol (2M):
380.07K

Business Description

Description
Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. It has one operating segment, which is the business of developing and commercializing proprietary therapeutic. Geographically, it is located in the United States.
Name Current Vs Industry Vs History
Cash-To-Debt 66.19
Equity-to-Asset 0.8
Debt-to-Equity 0.01
Debt-to-EBITDA -0.02
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -3.71
Distress
Grey
Safe
Beneish M-Score -2.49
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 63.78
9-Day RSI 64.21
14-Day RSI 64.23
6-1 Month Momentum % 31.43
12-1 Month Momentum % 16.75

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.89
Quick Ratio 4.54
Cash Ratio 3.96
Days Inventory 636.1
Days Sales Outstanding 83.27
Days Payable 351.88

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -5.6
Shareholder Yield % 0.55

Financials (Next Earnings Date:2025-03-13 Est.)

AADI's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:AADI

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Aadi Bioscience Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 25.07
EPS (TTM) ($) -2.28
Beta 0.62
Volatility % 78.94
14-Day RSI 64.23
14-Day ATR ($) 0.242889
20-Day SMA ($) 2.4865
12-1 Month Momentum % 16.75
52-Week Range ($) 1.21 - 3.6
Shares Outstanding (Mil) 24.68

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Aadi Bioscience Inc Filings

Filing Date Document Date Form
No Filing Data

Aadi Bioscience Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Aadi Bioscience Inc Frequently Asked Questions

What is Aadi Bioscience Inc(AADI)'s stock price today?
The current price of AADI is $3.00. The 52 week high of AADI is $3.60 and 52 week low is $1.21.
When is next earnings date of Aadi Bioscience Inc(AADI)?
The next earnings date of Aadi Bioscience Inc(AADI) is 2025-03-13 Est..
Does Aadi Bioscience Inc(AADI) pay dividends? If so, how much?
Aadi Bioscience Inc(AADI) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1